Abbott, Enanta hope hepatitis C drug will boost market FDA, EMEA adopt orphan drug report system Merck buys Millipore FDA accepts regulatory application for Qnexa Bioscrip reports losses in 2009 Regulus, GSK develop hepatitis C therapies FDA approves Shire's Type 1 Gaucher disease Study finds bitter melon may reduce breast cancer risk Genentech reports positive clinical results in Avastin trial Report projects breast cancer drug sales to exceed $1 billion First Previous 209 210 211 212 213 Next Last
